Comparison of olanzapine and haloperidol and quetiapine on delirium
Phase 3
Recruiting
- Conditions
- Delirium.Delirium due to known physiological condition
- Registration Number
- IRCT20200927048852N1
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
All patients who have been diagnosed with delirium by the 5th edition of Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria and have suffered a brain injury
Exclusion Criteria
primary neurological diseases such as stroke, dementia, psychosis
pregnancy and lactation
modified QT interval more than 440 milliseconds
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sedation. Timepoint: Before the intervention and the third, seventh and tenth days after the intervention. Method of measurement: Richmond Agitation and Sedation Scale.;Illness severity. Timepoint: Before the intervention and the third, seventh and tenth days after the start of the intervention. Method of measurement: Acute Physiology and Chronic Health Evaluation II.
- Secondary Outcome Measures
Name Time Method